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Abstract
Non Alcoholic Fatty Liver Disease
(NAFLD) is characterised by fat accumula-
tion in hepatocytes in the form of triacyg-
lycerols (TAGs) within cytosolic lipid
droplets. Fucoidans (FUs) are biologically
active polysaccharides usually isolated
from brown marine algae, but recently iden-
tified also in terrestrial plants. In this study,
we aimed to investigate the anti-oxidant and
anti-steatotic effects of FUs purified from
C. compressa, F. hermonis, and E. globulus.
To this aim, we used a validated NAFLD in
vitro model consisting of rat hepatoma FaO
cells exposed to an oleate/palmitate mix-
ture. Such a model is suitable for rapid
investigation of direct effects of natural and
artificial compounds, together with satisfy-
ing the strategy of 3Rs for laboratory use of
animals. Our results indicated that all FUs
display anti-oxidant and anti-steatotic activ-
ities. Steatotic FaO cells may be employed
to further study the biological effects of
FUs.
Introduction
Non Alcoholic Fatty Liver Disease
(NAFLD) is the most common cause of
liver disorders with high negative impact on
human health. It is characterized by fat
accumulation in more than 5% of hepato-
cyte, stored in the form of triacylglycerols
(TAGs) within cytosolic lipid droplets
(LDs), as a result of hepatic lipid metabo-
lism unbalance. Molecular mechanisms and
therapeutic strategies for NAFLD can be
studied using in vivo models, which offer
the advantage to study the effects of active
compounds at the level of the whole organ-
ism. However, major disadvantages are eth-
ical concerns, requirement of skilled man-
power, time consuming protocols and high
costs, thus supporting the application of in
vitro models which may satisfy the strategy
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Figure 1. Schematic description of different in vivo and in vitro NAFLD experimental models with reference to the 3R strategy; the










of 3 Rs (i.e. reduction, refinement and
replacement) for laboratory use of animals.1
In the last years our group used both in vivo
and in vitro models to study NAFLD, and
demonstrated that the main markers of
hepatic steatosis are maintained in all the
experimental models, thus making the in
vitro model suitable for rapid investigation
of direct anti-steatotic effects of natural and
artificial compounds. In the present study,
we used an in vitro model of NAFLD to
study the anti-oxidant and anti-steatotic
effects of fucoidans (FUs). FUs are fucose
rich polysaccharides predominantly found
in the cell wall of brown algae such as
Cystoseira compressa, but recently identi-
fied also in terrestrial plants such as
Eucalyptus globulus and Ferula hermonis,
growing in Lebanon. 
Materials and Methods
FUs were purified from C. compressa
(CYS), F. hermonis (FER), and E. globulus
(EUC) as previously described.2 Anti-oxi-
dant activity was determined by DPPH test.
Steatotic rat hepatoma FaO cells were
obtained by 3 h exposure to an
oleate/palmitate (OP) mixture and then
exposed to 50 μg/mL FUs for 24 h.1,3 The
anti-steatotic effect of FUs was investigated
by measuring intracellular TAG content and
by detecting LD formation through fluores-
cence microscopy. The expression of PPAR
(Peroxisome Proliferator Activated
Receptor) isoforms and LD associated per-
ilipins (PLINs) that play important roles in
lipid homeostasis, was evaluated by qPCR.3
Results
The upper part of Figure 1 shows that a
dramatic decrease in animal use and a high
speeding up of the experimental procedures
can be appreciated when comparing the
number of animals needed and the duration
of the treatments used in vivo and in vitro to
obtain three different models of NAFLD.
The lower part of Figure 1 shows the detec-
tion of LDs by Bodipy fluorescent staining
in OP-treated FaO cells with respect to con-
trol (Ctrl) cells; the table shows that intra-
cellular TAG content was significantly
reduced in steatotic cells upon any FU treat-
ment. This result was in line with a suppres-
sion of lipogenic genes such as PPARγ,
PLIN2 and PLIN5, which was measured by
qPCR. DPPH assay allowed to demonstrate
a significant anti-oxidant activity, which
was exerted by FUs purified from all three
species (IC 50 was 158.5 ± 1.81, 152.9 ±
3.30, 4.466 ± 3.26 μg/mL for CYS, FER
and EUC, respectively). 
Of note, FUs purified from terrestrial
plants exerted stronger anti-oxidant and
anti-steatotic effects than those obtained
from marine brown algae, with E. globulus
FUs showing the highest activities. 
Conclusions
Different in vivo and in vitro models
have been established to resemble the most
important features of NAFLD. In vitro
approaches have the advantage of providing
a simple and highly reproducible model,
where the mechanisms can be studied
directly at the cellular level. Our results val-
idate the use of cell cultures as effectual
tools to replace the use of laboratory ani-
mals when studying NAFLD and the effects
and mechanisms of action of natural com-
pounds with therapeutic potential, such as
FUs. Steatotic FaO cells may be employed
to further study the biological effects of
FUs, particularly those extracted from E.
globulus, which is confirmed as a powerful
medicinal plant.
References 
1. Grasselli E, Canesi L, Portincasa P, et
al. Models of non-Alcoholic Fatty Liver
Disease and Potential Translational
Value: the Effects of 3,5-L-diiodothyro-
nine. Ann Hepatol 2017;16:707-19.
2. Zein S, Haddad M, Krivoruchko E, et
al. A New Molecule of Water-Soluble
Polysaccharide Isolated from
Eucalyptus Growing in Lebanon. Eur J
Pharm Res 2018;1:48-54.
3. Grasselli E, Cortese K, Fabbri R, et al.
Thyromimetic actions of tetrabromo-
bisphenol A (TBBPA) in steatotic FaO
rat hepatoma cells. Chemosphere
2014;112:511-8.
[page 14]                                           [Biomedical Science and Engineering 2019; 3(s3):109]
                             Article
No
n-c
om
me
rci
al 
u
e o
nly
